You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
|
|---|---|
| Published in |
Journal of Hematology & Oncology, July 2021
|
| DOI | 10.1186/s13045-021-01109-y |
| Pubmed ID | |
| Authors |
Christopher T. Su, J. Christine Ye |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 40% |
| Algeria | 1 | 20% |
| Unknown | 2 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 60% |
| Scientists | 2 | 40% |
Mendeley readers
The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 44 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 6 | 14% |
| Student > Bachelor | 6 | 14% |
| Student > Ph. D. Student | 4 | 9% |
| Other | 3 | 7% |
| Student > Master | 3 | 7% |
| Other | 3 | 7% |
| Unknown | 19 | 43% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 8 | 18% |
| Biochemistry, Genetics and Molecular Biology | 7 | 16% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 7% |
| Chemical Engineering | 1 | 2% |
| Business, Management and Accounting | 1 | 2% |
| Other | 5 | 11% |
| Unknown | 19 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 September 2021.
All research outputs
#12,928,513
of 23,310,485 outputs
Outputs from Journal of Hematology & Oncology
#597
of 1,208 outputs
Outputs of similar age
#169,882
of 436,123 outputs
Outputs of similar age from Journal of Hematology & Oncology
#22
of 48 outputs
Altmetric has tracked 23,310,485 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,208 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 436,123 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.